E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/14/2006 in the Prospect News Bank Loan Daily and Prospect News Biotech Daily.

SFBC amends loan, waiving non-compliance with covenants

By Sara Rosenberg

New York, Aug. 14 - SFBC International Inc. amended its credit facility, waiving all covenants that the company was unable to comply with until Sept. 29, according to a 10-Q filed with the Securities and Exchange Commission Monday.

The company paid a 7.5 basis point amendment fee.

The amendment was completed on Aug. 11.

SFBC is a Princeton, N.J.-based drug development services company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.